E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis
暂无分享,去创建一个
M. Neurath | Wei Li | A. Kühl | S. Wirtz | R. Atreya | K. Jacobson | C. Becker | C. Günther | Srinivas Kantham | M. Leppkes | C. Neufert | R. Young | S. Zundler | Christina Heichler | M. J. Mathew | Barbara Ruder | F. Mascia | Yuqiang Yu | Mousumi Mahapatro | Miguel Gonzalez Acera | Kristina Scheibe | J. Paquette | Jay V Patankar | T. Müller | M. Mathew
[1] Alexander R. Pico,et al. WikiPathways: connecting communities , 2020, Nucleic Acids Res..
[2] K. Rogers,et al. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells , 2020, Cell Death & Differentiation.
[3] Guo Zhang,et al. Association between PTGER4 polymorphisms and inflammatory bowel disease risk in Caucasian , 2020, Medicine.
[4] C. Becker,et al. Cell death in the gut epithelium and implications for chronic inflammation , 2020, Nature reviews: Gastroenterology & hepatology.
[5] R. Paulssen,et al. Transcriptional Signatures That Define Ulcerative Colitis in Remission , 2020, Inflammatory bowel diseases.
[6] O. Nielsen,et al. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases , 2020, Science Signaling.
[7] H. Seno,et al. Epithelial EP4 plays an essential role in maintaining homeostasis in colon , 2019, Scientific Reports.
[8] G. Kollias,et al. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. , 2019, Gastroenterology.
[9] Gui-Qiu Hu,et al. MLKL deficiency inhibits DSS‐induced colitis independent of intestinal microbiota , 2019, Molecular immunology.
[10] M. Neurath,et al. Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation , 2019, Nature Immunology.
[11] S. Shen-Orr,et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response , 2019, Nature Communications.
[12] H. Clevers,et al. Intestinal Inflammation and Dysregulated Immunity in Patients With Inherited Caspase-8 Deficiency. , 2019, Gastroenterology.
[13] T. Hirokawa,et al. Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface , 2018, Nature Chemical Biology.
[14] J. Bertin,et al. Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.
[15] H. Wajant,et al. Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis , 2018, Cell Death & Disease.
[16] D. Aronoff,et al. COX-2–PGE2 Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis , 2018, EBioMedicine.
[17] Junying Yuan,et al. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging , 2018, Cell.
[18] M. Neurath,et al. Resolution of chronic inflammatory disease: universal and tissue-specific concepts , 2018, Nature Communications.
[19] B. Levy,et al. PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo , 2017, Science Advances.
[20] Junying Yuan,et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis , 2017, Nature Communications.
[21] Zhigao Wang,et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis , 2017, Proceedings of the National Academy of Sciences.
[22] G. Rogler. Resolution of inflammation in inflammatory bowel disease. , 2017, The lancet. Gastroenterology & hepatology.
[23] I. Brodsky,et al. NAIP‐NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL‐18 Release via Activation of Caspase‐1 and ‐8 , 2017, Immunity.
[24] I. Mlinarič-Raščan,et al. Structural features of subtype-selective EP receptor modulators. , 2017, Drug discovery today.
[25] P. Vandenabeele,et al. The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. , 2016, The Journal of clinical investigation.
[26] Haifeng Yin,et al. TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints , 2016, Cell Death and Disease.
[27] M. Bertrand,et al. More to Life than NF-κB in TNFR1 Signaling. , 2016, Trends in immunology.
[28] J. Ninomiya-Tsuji,et al. TAK1 regulates Paneth cell integrity partly through blocking necroptosis , 2016, Cell Death and Disease.
[29] T. Taniguchi,et al. PGE2 induced in and released by dying cells functions as an inhibitory DAMP , 2016, Proceedings of the National Academy of Sciences.
[30] R. Maizels,et al. Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell–IL-22 axis , 2016, Science.
[31] Ryan Miller,et al. WikiPathways: capturing the full diversity of pathway knowledge , 2015, Nucleic Acids Res..
[32] Isabelle Cleynen,et al. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[33] Albert J R Heck,et al. PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks. , 2015, Journal of proteome research.
[34] A. Rosenwald,et al. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD. , 2015, Blood.
[35] Takuji Tanaka,et al. KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. , 2015, European journal of pharmacology.
[36] Junying Yuan. Faculty Opinions recommendation of Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. , 2015 .
[37] J. Bertin,et al. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death , 2015, Cell Death and Disease.
[38] Timothy L. Tickle,et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.
[39] Jie Huang,et al. Notch3 pathway alterations in ovarian cancer. , 2014, Cancer research.
[40] M. Bertrand,et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. , 2014, Cell reports.
[41] Jiahuai Han,et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death , 2013, Cell Research.
[42] C. Falcone,et al. Role of the advanced glycation end products receptor in Crohn's disease inflammation. , 2013, World journal of gastroenterology.
[43] R. Duerr,et al. PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-κB and XBP1 Binding Sites , 2012, PloS one.
[44] Akhilesh Pandey,et al. A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway , 2012, Journal of signal transduction.
[45] R. Young,et al. Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis. , 2012, Bioorganic & medicinal chemistry.
[46] Xiaodong Wang,et al. Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.
[47] S. Pervaiz,et al. Biphasic activity of CD137 ligand‐stimulated monocytes on T cell apoptosis and proliferation , 2011, Journal of leukocyte biology.
[48] C. Gullo,et al. Inhibition of Proliferation and Induction of Apoptosis in Multiple Myeloma Cell Lines by CD137 Ligand Signaling , 2010, PloS one.
[49] S. Narumiya,et al. Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. , 2010, Inflammatory bowel diseases.
[50] G Van Assche,et al. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis , 2009, Gut.
[51] Tao Wang,et al. Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.
[52] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[53] I. Petersen,et al. Prevalence of infectious pathogens in Crohn's disease. , 2009, Pathology, research and practice.
[54] Jack Satsangi,et al. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis , 2008, Gut.
[55] R. Faccio,et al. RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. , 2008, The Journal of clinical investigation.
[56] Simon Heath,et al. Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.
[57] Mike Tyers,et al. BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..
[58] D. Graves,et al. Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways* , 2005, Journal of Biological Chemistry.
[59] T. Mizoguchi,et al. Prostaglandin E2 Enhances Osteoclastic Differentiation of Precursor Cells through Protein Kinase A-dependent Phosphorylation of TAK1* , 2005, Journal of Biological Chemistry.
[60] R. Young. Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist , 2004 .
[61] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[62] ハン,ヨンシン,et al. Ep4 receptor agonist, compositions and methods thereof , 2003 .
[63] R. Young,et al. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. , 2003, Bioorganic & medicinal chemistry letters.
[64] S. Narumiya,et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. , 2002, The Journal of clinical investigation.
[65] Sumio Watanabe,et al. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis , 2002, International Journal of Colorectal Disease.
[66] J. Morrow,et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.
[67] T. Koji,et al. APOPTOSIS OF CRYPT EPITHELIAL CELLS IN ULCERATIVE COLITIS , 1996, The Journal of pathology.